Join the fight against IBD

EFCCA, in partnership with ECCO, is pleased to invite you to "Join the fight against IBD" and attend, journalists and delegates from all our member associations, a special event on February the 15th in Barcelona prior to the 7th Congress of ECCO.
Press release

Results of a European wide survey on the impact of IBD on life shows worrying figures
The European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA) which represents patients of Crohn’s disease and ulcerative colitis (collectively known as inflammatory bowel diseases or IBD) recently conducted a Europe wide survey to provide an overview of the “real impact” of IBD on patients lives covering not only medical issues but also additional aspects such as quality of life, education, employment, relationships and others.
“The participation of over 6000 IBD patients throughout Europe has completely exceeded out expectations.” says Marco Greco, EFCCA chairman “sadly, the impact of IBD in our lives is sometimes still at an unacceptable levelas can be seen from the main findings of the survey”
IPODD ... EU research project on IBD
IPODD translations can be found here:
The EU project IPODD takes a pragmatic approach to IBDs by focusing on the final stages of gut damage.
Sergio Pistoi, IPODD Public Information Officer*
If criminals were behind inflammatory bowel diseases (IBDs), it would be a band of terrorists, not lonely felons. Dozens of predisposing genes, the immune system and maybe tens of other unknown factors conspire to determine IBDs. There is no puppeteer pulling the strings in these diseases but,rather,an articulate network of causes that ultimately leads to chronic inflammation and damage.
Subcategories
-
Clinical Trials
EFCCA Clinical Trial News
EFCCA is pleased to bring you some scientific and medical articles related to IBD for your information. EFCCA cannot accept any liability for the accuracy of the information, or for the use of it. Whilst discussion of potential therapies has academic value, EFCCA would like to remind all readers that no claims are made on the effectiveness or safety of any treatment, and that readers should always consult their healthcare professional if they have any concerns or questions, and before taking any action based on the information.


